Explore the challenges in insurance coverage for GLP-1 weight-loss medications as demand rises and insurers tighten restrictions.

Explore how Medicare Part B payment adjustments for self-administered medications impact beneficiaries and the healthcare market.

UCB's $2B investment in Atlanta and Florida's HIV medication expansion highlight key health industry trends. Explore the impacts and implications for healthcare.

Explore innovative pricing models for GLP-1 medications addressing accessibility issues created by insurance denials. Discover direct purchase options and Medicare initiatives.

Explore new healthcare regulations affecting insurance claims. Understand the impact of major legal shifts and the evolving healthcare landscape for professionals.

Discover how recent Medicare changes are improving medication adherence and access for seniors, particularly those with cardiovascular conditions.

CorMedix expands its portfolio with injectable therapies, focusing on DefenCath and leveraging strategic growth initiatives in healthcare. Learn more about their approach.

Discover how CorMedix is expanding its drug pipeline and adapting strategies for reimbursement in the evolving healthcare landscape.

Discover how CorMedix is advancing its initiatives and adapting to reimbursement changes in specialty pharmaceuticals at the Citizens Life Sciences Conference.

Explore the implications of Medicare's Drug Price Negotiation Program, its impact on costs, and the ongoing negotiations for 2028. Discover key details.